Calosens

Calosens is developing an analytical device for the in-vitro-diagnostics market that allows to analyse probes much faster, more sensitive (+/- 3nW) and more specific

Calosens is developing an analytical device for the in-vitro-diagnostics market that allows to analyse probes much faster, more sensitive (+/- 3nW) and more specific. In cases of bacterial infections (Meningitis/Sepsis) there is still a high mortality rate of up to 30% as the adequate medication and dose can not be appointed fast enough. This will improve with our device resulting in higher survival rates and reducing the risks of building new antibiotic resistance.

Calosens

William Lüthi


Contact

Sharing

Support

Awards (1)

A PHILANTHROPIC INITIATIVE OF A PRIVATE CONSORTIUM

Turning scientific innovation into entrepreneurial activity and job creation is the basis of societal and economical prosperity. In the very early stages, startups bear very high risks that are neither carried by public money nor by private investors. Supporting seed stage startups fills a crucial gap and is therefore purely philanthropic.
Read more about the Foundation of Founders